Acorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
- ByInvesting.com-
Acorda Therapeutics , Inc. (Nasdaq: NASDAQ:ACOR) today announced that it will conduct a reverse stock split of its outstanding and authorized shares of common stock at a ratio...